These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 27082190)

  • 1. The Cancer Defense.
    Weintraub K
    Sci Am; 2016 Apr; 314(4):42-51. PubMed ID: 27082190
    [No Abstract]   [Full Text] [Related]  

  • 2. One size does not fit all: personalized immune therapies poised to take center stage.
    Azvolinsky A
    J Natl Cancer Inst; 2013 May; 105(9):583-4. PubMed ID: 23591459
    [No Abstract]   [Full Text] [Related]  

  • 3. [Active specific immunotherapy of cancer using anti-idiotypic monoclonal antibodies].
    Castello G; D'Alessio V
    Clin Ter; 1991 May; 137(3):155-67. PubMed ID: 1831084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety concerns blight promising cancer therapy.
    Ledford H
    Nature; 2016 Oct; 538(7624):150-151. PubMed ID: 27734893
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunotherapy of cancer.
    Salmon SE; Jones SE
    Ariz Med; 1977 Jun; 34(6):396-8. PubMed ID: 880051
    [No Abstract]   [Full Text] [Related]  

  • 6. Donor-derived CD19 chimeric antigen receptor T cells.
    Singh N; Barrett DM
    Curr Opin Hematol; 2015 Nov; 22(6):503-8. PubMed ID: 26457962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonspecific immunotherapy of malignant tumors.
    Milas L; Withers HR
    Radiology; 1976 Jan; 118(1):211-8. PubMed ID: 1105663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCG as adjuvant immunotherapy for neoplasia.
    Hersh EM; Gutterman JU; Mavligit GM
    Annu Rev Med; 1977; 28():489-515. PubMed ID: 324372
    [No Abstract]   [Full Text] [Related]  

  • 9. [New immunotherapy for patients with neoplasms using tumor antigens recognized by T lymphocytes].
    Kawakami Y
    Nihon Naika Gakkai Zasshi; 1998 Dec; 87(12):2536-44. PubMed ID: 9922678
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunotherapy of melanoma.
    Parmiani G; Castelli C; Rivoltini L; Casati C; Tully GA; Novellino L; Patuzzo A; Tosi D; Anichini A; Santinami M
    Semin Cancer Biol; 2003 Dec; 13(6):391-400. PubMed ID: 15001157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [General principles and first clinical trials of therapeutic vaccines against cancer].
    Baurain JF; Van der Bruggen P; Van den Eynde BJ; Coulie PG; Van Baren N
    Bull Cancer; 2008 Mar; 95(3):327-35. PubMed ID: 18390413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer T cell therapy expands.
    Becknell B; Caligiuri MA
    Nat Med; 2003 Mar; 9(3):257-8. PubMed ID: 12612567
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunotherapy of cancer].
    Mäkelä O; Kaartinen M
    Duodecim; 1973; 89(18):1257-62. PubMed ID: 4771796
    [No Abstract]   [Full Text] [Related]  

  • 14. Cell transfer and other immunotherapeutic strategies.
    Rosenberg SA
    Clin Adv Hematol Oncol; 2005 Jan; 3(1):28-9. PubMed ID: 16166964
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunologic stimulation of respiratory tract defenses against infection].
    Poumon Coeur; 1973; 29(4):479-95. PubMed ID: 4546561
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of effective immunotherapy for the treatment of patients with cancer.
    Rosenberg SA
    J Am Coll Surg; 2004 May; 198(5):685-96. PubMed ID: 15110801
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunology of melanoma].
    Bröcker EB; Becker JC
    Hautarzt; 1995 Nov; 46(11):818-28. PubMed ID: 8641893
    [No Abstract]   [Full Text] [Related]  

  • 18. [Future of malignant stage I melanoma. Immunology and immunotherapy].
    Nicolas JF; Berthier O; Trillet-Lenoir V; Claudy A; Revillard JP
    Ann Dermatol Venereol; 1995; 122(5):324-35. PubMed ID: 8572476
    [No Abstract]   [Full Text] [Related]  

  • 19. Cancer immunotherapy.
    Prestwich R; Vile R; Melcher A
    N Engl J Med; 2008 Sep; 359(10):1072; author reply 1073. PubMed ID: 18777615
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunologically-mediated tumour cell apoptosis: the role of TRAIL in T cell and cytokine-mediated responses to melanoma.
    Nguyen T; Thomas W; Zhang XD; Gray C; Hersey P
    Forum (Genova); 2000; 10(3):243-52. PubMed ID: 11007932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.